NewAmsterdam Pharma Company
NAMS
$20.09
Share price
0.20%
Change (1 day)
68.82%
Change (1 year)
Categories
P/S ratio for NewAmsterdam Pharma Company (NAMS)
P/S ratio at the end of 2023: 65.3
According to NewAmsterdam Pharma Company's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 128.049. At the end of 2023 the company had a P/S ratio of 65.3.
P/S ratio history for NewAmsterdam Pharma Company from 2022 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 65.3 | 664.6% |
| 2022 | 8.54 |